These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16075289)

  • 21. Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength.
    Lei G; Anastasio NC; Fu Y; Neugebauer V; Johnson KM
    J Neurochem; 2009 May; 109(4):1017-30. PubMed ID: 19519774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
    Gobert A; Di Cara B; Cistarelli L; Millan MJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D(2) receptors and ingestive behavior: brainstem mediates inhibition of intraoral intake and accumbens mediates aversive taste behavior in male rats.
    Sederholm F; Johnson AE; Brodin U; Södersten P
    Psychopharmacology (Berl); 2002 Mar; 160(2):161-9. PubMed ID: 11875634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.
    Reid RT; Lloyd GK; Rao TS
    Br J Pharmacol; 1999 Jul; 127(6):1486-94. PubMed ID: 10455300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
    Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
    Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.
    Gilmore JH; Watts VJ; Lawler CP; Noll EP; Nichols DE; Mailman RB
    Neuropharmacology; 1995 May; 34(5):481-8. PubMed ID: 7566481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D1 dopamine receptor mediation of social and nonsocial emotional reactivity in mice: effects of housing and strain difference in motor activity.
    Gendreau PL; Gariépy JL; Petitto JM; Lewis MH
    Behav Neurosci; 1997 Apr; 111(2):424-34. PubMed ID: 9106681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats.
    Di Cara B; Panayi F; Gobert A; Dekeyne A; Sicard D; De Groote L; Millan MJ
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):383-99. PubMed ID: 16925890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G; Robertson GS; Tham CS; Fibiger HC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
    Heidenreich BA; Mailman RB; Nichols DE; Napier TC
    J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
    George MS; Molnar CE; Grenesko EL; Anderson B; Mu Q; Johnson K; Nahas Z; Knable M; Fernandes P; Juncos J; Huang X; Nichols DE; Mailman RB
    Schizophr Res; 2007 Jul; 93(1-3):42-50. PubMed ID: 17467956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D1/5 receptor modulation of firing rate and bidirectional theta burst firing in medial septal/vertical limb of diagonal band neurons in vivo.
    Fitch TE; Sahr RN; Eastwood BJ; Zhou FC; Yang CR
    J Neurophysiol; 2006 May; 95(5):2808-20. PubMed ID: 16452256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
    Gulwadi AG; Korpinen CD; Mailman RB; Nichols DE; Sit SY; Taber MT
    J Pharmacol Exp Ther; 2001 Feb; 296(2):338-44. PubMed ID: 11160615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues.
    Cueva JP; Gallardo-Godoy A; Juncosa JI; Vidi PA; Lill MA; Watts VJ; Nichols DE
    J Med Chem; 2011 Aug; 54(15):5508-21. PubMed ID: 21714510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.